Literature DB >> 32479927

Atrial fibrillation in the elderly: a risk factor beyond stroke.

Leonardo Bencivenga1, Klara Komici2, Pierangela Nocella3, Fabrizio Vincenzo Grieco3, Angela Spezzano3, Brunella Puzone3, Alessandro Cannavo3, Antonio Cittadini3, Graziamaria Corbi2, Nicola Ferrara4, Giuseppe Rengo5.   

Abstract

Atrial fibrillation (AF) represents the most common arrhythmia worldwide and its prevalence exponentially increases with age. It is related to increased risk of ischemic stroke or systemic embolism, which determines a significant burden of morbidity and mortality, as widely documented in the literature. AF also constitutes a risk factor for other less investigated conditions, such as heart failure, pulmonary embolism, impairment in physical performance, reduced quality of life, development of disability, mood disorders and cognitive impairment up to dementia. In the elderly population, the management of AF and its complications is particularly complex due to the heterogeneity of the ageing process, the lack of specific evidence-based recommendations, as well as the high grade of comorbidity and disability characterizing the over 65 years aged people. In the present review, we aim to summarize the pieces of the most updated evidence on AF complications beyond stoke, mainly focusing on the elderly population.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cognitive impairment; Elderly; Heart failure; Mood disorders; Physical impairment; Quality of life

Mesh:

Year:  2020        PMID: 32479927     DOI: 10.1016/j.arr.2020.101092

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  7 in total

1.  Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis.

Authors:  Igor Diemberger; Stefano Fumagalli; Anna Maria Mazzone; Ameet Bakhai; Paul Egbert Reimitz; Ladislav Pecen; Marius Constantin Manu; José Antonio Gordillo de Souza; Paulus Kirchhof; Raffaele De Caterina
Journal:  Europace       Date:  2022-10-13       Impact factor: 5.486

2.  miR-29b ameliorates atrial fibrosis in rats with atrial fibrillation by targeting TGFβRΙ and inhibiting the activation of Smad-2/3 pathway.

Authors:  Xinyuan Han; Shunda Wang; Zhijun Yong; Xueting Zhang; Xuanqi Wang
Journal:  J Bioenerg Biomembr       Date:  2022-03-24       Impact factor: 3.853

3.  Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Med Sci Monit       Date:  2022-02-27

4.  Rotor hypothesis in the time chain of atrial fibrillation.

Authors:  Chang-Hao Xu; Xu Liu
Journal:  J Geriatr Cardiol       Date:  2022-04-28       Impact factor: 3.327

5.  Retrospective Study from a Single Center to Evaluate the Association Between Sex and Serum Uric Acid Levels in 950 Patients with Atrial Fibrillation.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Med Sci Monit       Date:  2022-05-12

6.  Prevalence of atrial fibrillation and the risk of cardiovascular mortality among hypertensive elderly population in northeast China.

Authors:  Zhenwei Xia; Wei Dang; Xue Yang; Qun Sun; Jixu Sun; Lei Shi; Shize Sun; Le An; Xiaojing Li; Hongbo Peng; Shuang Liu; Ling Yue; Hongyun Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-04-18       Impact factor: 2.885

7.  Prevalence, risk factors, and prediction of inappropriate use of non-vitamin K antagonist oral anticoagulants in elderly Chinese patients with atrial fibrillation: A study protocol.

Authors:  Shu-Juan Zhao; Bo-Ya Chen; Xue-Jiao Hong; Yin-Ping Liu; Hai-Xia Cai; Song Du; Zhi-Chun Gu; Pei-Zhi Ma
Journal:  Front Cardiovasc Med       Date:  2022-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.